Complete Versus Culprit-Only Revascularization Strategies to Treat Multivessel Disease after Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction
Ahmad Musallam, Khalid Elrabbat, Mohamed Tabl, Hager Allam
{"title":"Complete Versus Culprit-Only Revascularization Strategies to Treat Multivessel Disease after Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction","authors":"Ahmad Musallam, Khalid Elrabbat, Mohamed Tabl, Hager Allam","doi":"10.21608/bmfj.2024.235710.1898","DOIUrl":null,"url":null,"abstract":": Background: Acute myocardial infarction with multivessel disease represents a higher cardiovascular risk and revascularization strategy in such patients remains a subject of conflict. The aim of our study was to assess the potential benefit of complete revascularization as compared to culprit vessel only revascularization in ST-segment elevation myocardial infarction (STEMI) patients who has multivessel disease (MVD). Methods: The current study is a single center prospective study conducted on 150 Patients presented with acute ST-segment elevation myocardial infarction to emergency department (ED) and cardiac care unit (CCU) in Nasr City Hospital, and according to revascularization strategy, patients were divided into two groups; Group I: patients received complete revascularization before hospital discharge and Group II: patients receiving culprit-only revascularization. Results: There was significant lower MACE in group I (p<0.05). The occurrence of non-ST segment acute coronary syndrome (NSTE-ACS) as well as the need for ischemia-driven revascularization-were significantly lower in the complete revascularization group (p=0.028 & p=0.008), respectively. Conclusion: in STEMI patients with multivessel disease, complete revascularization-as compared to culprit-only revascularization strategy-reduced MACE and improved short-term outcome.","PeriodicalId":503219,"journal":{"name":"Benha Medical Journal","volume":"114 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Benha Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/bmfj.2024.235710.1898","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
: Background: Acute myocardial infarction with multivessel disease represents a higher cardiovascular risk and revascularization strategy in such patients remains a subject of conflict. The aim of our study was to assess the potential benefit of complete revascularization as compared to culprit vessel only revascularization in ST-segment elevation myocardial infarction (STEMI) patients who has multivessel disease (MVD). Methods: The current study is a single center prospective study conducted on 150 Patients presented with acute ST-segment elevation myocardial infarction to emergency department (ED) and cardiac care unit (CCU) in Nasr City Hospital, and according to revascularization strategy, patients were divided into two groups; Group I: patients received complete revascularization before hospital discharge and Group II: patients receiving culprit-only revascularization. Results: There was significant lower MACE in group I (p<0.05). The occurrence of non-ST segment acute coronary syndrome (NSTE-ACS) as well as the need for ischemia-driven revascularization-were significantly lower in the complete revascularization group (p=0.028 & p=0.008), respectively. Conclusion: in STEMI patients with multivessel disease, complete revascularization-as compared to culprit-only revascularization strategy-reduced MACE and improved short-term outcome.